On December 26, Johnson & Johnson (NYSE:JNJ) said it ended a mid-stage study of an experimental drug for patients with ...

As a result, finding a compatible dermatologist and solution to eczema is not just logistically difficult but often ...

On Monday, December 29, Tower 28 is launching SOS Rescue + Relief Body Wash, a derm-approved, hypoallergenic, pH-balanced ...

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...

Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new ...

An international team of investigators led by Emma Guttman-Yassky, MD, PhD, Waldman Professor and System Chair of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of ...

"In some cases, you could have more intense symptoms when you're transitioning to a new medication, but there are also situations where a drug you've used for a while isn't managing your condition as ...

A BBC health expert has provided an encouraging update on a new drug that has been approved for the treatment of eczema, a debilitating skin condition. The drug, delgocitinib, also known as Anzupgo ...

A BBC health expert has shared a promising update on a new drug that has been approved for the treatment of eczema, a debilitating skin condition, which will help more than 62,000 people in England.